A new approach for MS.
Morrow
Thomas
T
National Association of Managed Care Physicians, USA.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D017277:Drug Approval; D006801:Humans; D008329:Managed Care Programs; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab